Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

317 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Untangling the ErbB signalling network.
Yarden Y, Sliwkowski MX. Yarden Y, et al. Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37. doi: 10.1038/35052073. Nat Rev Mol Cell Biol. 2001. PMID: 11252954 Review.
A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.
Yayon A, Zimmer Y, Shen GH, Avivi A, Yarden Y, Givol D. Yayon A, et al. Among authors: yarden y. EMBO J. 1992 May;11(5):1885-90. EMBO J. 1992. PMID: 1316275 Free PMC article.
Cytoplasmic control of cell adhesion.
Geiger B, Ayalon O, Ginsberg D, Volberg T, Rodríguez Fernández JL, Yarden Y, Ben-Ze'ev A. Geiger B, et al. Among authors: yarden y. Cold Spring Harb Symp Quant Biol. 1992;57:631-42. doi: 10.1101/sqb.1992.057.01.069. Cold Spring Harb Symp Quant Biol. 1992. PMID: 1339701 No abstract available.
Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y. Peles E, et al. Among authors: yarden y. Cell. 1992 Apr 3;69(1):205-16. doi: 10.1016/0092-8674(92)90131-u. Cell. 1992. PMID: 1348215
Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation.
Peles E, Lamprecht R, Ben-Levy R, Tzahar E, Yarden Y. Peles E, et al. Among authors: yarden y. J Biol Chem. 1992 Jun 15;267(17):12266-74. J Biol Chem. 1992. PMID: 1351056
An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
Ben-Levy R, Peles E, Goldman-Michael R, Yarden Y. Ben-Levy R, et al. Among authors: yarden y. J Biol Chem. 1992 Aug 25;267(24):17304-13. J Biol Chem. 1992. PMID: 1355090
Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.
Stancovski I, Peles E, Ben Levy R, Lemprecht R, Kelman Z, Goldman-Michael R, Hurwitz E, Bacus S, Sela M, Yarden Y. Stancovski I, et al. Among authors: yarden y. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):95-103. doi: 10.1016/0960-0760(92)90192-l. J Steroid Biochem Mol Biol. 1992. PMID: 1356018 Review.
Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.
Lev S, Givol D, Yarden Y. Lev S, et al. Among authors: yarden y. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):678-82. doi: 10.1073/pnas.89.2.678. Proc Natl Acad Sci U S A. 1992. PMID: 1370584 Free PMC article.
Biochemical analysis of the ligand for the neu oncogenic receptor.
Yarden Y, Peles E. Yarden Y, et al. Biochemistry. 1991 Apr 9;30(14):3543-50. doi: 10.1021/bi00228a027. Biochemistry. 1991. PMID: 1672825
Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.
Peles E, Levy RB, Or E, Ullrich A, Yarden Y. Peles E, et al. Among authors: yarden y. EMBO J. 1991 Aug;10(8):2077-86. EMBO J. 1991. PMID: 1676673 Free PMC article.
317 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback